French Post-Marketing Surveillance Survey.
Phase of Trial: Phase IV
Latest Information Update: 13 Aug 2014
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms FR-E-REGISTRY
- Sponsors Cordis Corporation
- 26 Nov 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 06 Mar 2009 New trial record